XML 42 R5.htm IDEA: XBRL DOCUMENT v3.25.2
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Apr. 30, 2023 $ 37,409 $ 7,084 $ 5,059 $ (53) $ 28,761 $ (3,442)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings (loss) attributable to Kewaunee Scientific Corporation 18,753       18,753  
Other comprehensive income (loss) 60         60
Stock based compensation 536 189 347      
Purchase of Treasury Stock (1,998)     (1,998)    
Ending balance at Apr. 30, 2024 $ 54,760 7,273 5,406 (2,051) 47,514 (3,382)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Treasury stock (in shares) 66,191          
Net earnings (loss) attributable to Kewaunee Scientific Corporation $ 11,405       11,405  
Other comprehensive income (loss) (421)         (421)
Stock based compensation 309 80 229      
Purchase of Treasury Stock (1,596)     (1,596)    
Ending balance at Apr. 30, 2025 $ 64,457 $ 7,353 $ 5,635 $ (3,647) $ 58,919 $ (3,803)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Treasury stock (in shares) 33,206